Low-Level Laser Therapy Treatment of Lung Inflammation in COVID-19 Patients
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 2
- 主要终点
- Inflammation of the lungs - CRP
研究概览
简要总结
To determine if a reduction of pneumonic inflammation occurs after treatment with Low-Level Laser Therapy (LLLT) applying red-light technology in the respiratory system of COVID-19 patients suffering from acute viral pneumonia.
详细描述
This clinical trial is a blinded before and after comparison of the effect on patients treated with a red-light LLLT therapy for acute lung inflammation as a result of COVID-19 infection. Patients are enrolled to undergo LLLT therapy in addition to all standard ongoing therapies for COVID-19.
Outcomes for patients receiving LLLT in addition to their standard care (the treatment group) are compared to the group receiving only standard therapy for COVID-19 (control group). Effects of LLLT treatment are measured immediately following treatment, and outcome measurements are compared to the pre-treatment baseline.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
盲法说明
All participants undergo LLLT treatment; however, the active group receives LED light in the red and IR range while the placebo group is told they are receiving IR light not visible to naked eye. All participants continue receiving standard treatments for COVID19 symptoms.
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Participant is diagnosed with COVID-
- •Study participant is 18 years of age or older.
- •Patient exhibiting moderate-to-acute respiratory distress.
排除标准
- •Photosensitive condition or medication.
- •Active chemotherapy treatment or other cancer treatment.
- •Autoimmune Disorder.
- •Pregnant, possibly pregnant or planning pregnancy prior to the end of study participation.
- •Developmental disability or cognitive impairment that, in the opinion of the investigator, would preclude adequate comprehension of the informed consent form and/or ability to record the necessary study measurements.
结局指标
主要结局
Inflammation of the lungs - CRP
时间窗: 10 days
Change in inflammation of the lungs as measured by C-Reactive Protein (CRP) Test
Inflammation of the lungs - IL6
时间窗: 10 days
Change in inflammation of the lungs as measured by IL-6 Levels
Inflammation of the lungs - O2
时间窗: 10 days
Change in inflammation of the lungs as measured by O2 saturation levels
次要结局
未报告次要终点